Detection of platelet sensitivity to inhibitors of COX-1, P2Y1, and P2Y12 using a whole blood microfluidic flow assay

Thrombosis Research

Volumn 133, Issue 2, 2014, Pages 203-210

  Li, Ruizhi ^a   Diamond, Scott L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ADP; cyclooxygenase; hemodynamic; platelet; thromboxane

Indexed keywords

2 METHYLTHIOADENOSINE 5 PHOSPHATE; 2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; ACETYLSALICYLIC ACID; ADENOSINE PHOSPHATE; COLLAGEN; CYCLOOXYGENASE 1 INHIBITOR; PURINERGIC P2Y RECEPTOR ANTAGONIST; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; MICROFLUIDIC ANALYSIS; PRIORITY JOURNAL; SHEAR RATE; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION;

(ADP); (ASA); (COX-1); (TXA(2)); ADENOSINE DIPHOSPHATE; ADP; ASPIRIN; CYCLOOXYGENASE; CYCLOOXYGENASE 1; HEMODYNAMIC; PLATELET; THROMBOXANE; THROMBOXANE A(2);

ADENOSINE DIPHOSPHATE; ASPIRIN; BLOOD PLATELETS; CYCLOOXYGENASE 1; CYCLOOXYGENASE INHIBITORS; HUMANS; MICROFLUIDIC ANALYTICAL TECHNIQUES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PURINERGIC P2Y RECEPTOR ANTAGONISTS;

EID: 84892364929     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.10.043     Document Type: Article

References (23)

1. C.L. Campbell, S. Smyth, G. Montalescot, and SR. Steinhubl Aspirin Dose for the Prevention of Cardiovascular Disease JAMA 297 2007 2018 2024
2. J.R. Vane, and R.M. Botting The mechanism of action of aspirin Thromb Res 110 2003 255 258
3. L.F. Brass, T.J. Stalker, L. Zhu, and DS. Woulfe Signal Transduction During Platelet Plug formation A.D. Michelson, Platelets 2nd ed. 2007 Academic Press Boston 367 397
4. A.D. Michelson Antiplatelet therapies for treatment of cardiovascular disease Nat. Rev. Drug Discovery 9 2010 154 169
5. H. Chang, I.B. Yanachkov, E.J. Dix, YF Li, MR Barnard, and GE Wright et al. Modified diadenosine tetraphosphates with dual specificity for P2Y1 and P2Y12 are potent antagonists of ADP-induced platelet activation J Thromb Haemost 12 2012 2573 2580
6. T.V. Colace, J. Jobson, and S.L. Diamond Relipidated Tissue Factor Linked to Collagen Surfaces Potentiates Platelet Adhesion and Fibrin Formation in a Microfluidic Model of Vessel Injury Bioconjugate Chem 22 2011 2104 2109
7. T.V. Colace, R.W. Muthard, and S.L. Diamond Thrombus Growth and Embolism on Tissue Factor-Bearing Collagen Surfaces Under Flow: Role of Thrombin With and Without Fibrin Arterioscler Thromb Vasc Biol 32 2012 1466 1476
8. R.W. Muthard, and S.L. Diamond Blood clots are rapidly assembled hemodynamic sensors: Flow arrest triggers intraluminal thrombus contraction Arterioscler Thromb Vasc Biol 12 2012 2938 2945
9. T.J. Stalker, E.A. Traxler, J. Wu, KM Mannemacher, SL Cermignano, and R Voronov et al. Hierarchical organization in the hemostatic response and its relationship to the platelet signaling network Blood 121 2013 1875 1885
10. R.W. Muthard, and S.L. Diamond Side view thrombosis microfluidic device with controllable wall shear rate and transthrombus pressure gradient Lab Chip 13 2013 1883 1891
11. R. Li, S. Fries, and X. Li et al. Microfluidic Assay of Platelet Deposition on Collagen by Perfusion of Whole Blood from Healthy individuals taking aspirin Clin Chem 59 2013 1195 1204
12. M.H. Flamm, T.V. Colace, M.S. Chatterjee, H Jing, S Zhou, and D Jaeger et al. Multiscale prediction of patient specific platelet function under flow Blood 120 2012 190 198
13. 1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions Integr Biol 2 2010 183 192
14. J. Eng Receiver Operating Characteristic Analysis Acad Radiol 12 2005 909 916
15. P.A. Gurbel, K.P. Bliden, J. DiChia, J Newcomer, W Weng, and NK Neerchal Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study Circulation 115 2007 3156 3164
16. C.S. Rinder, L.A. Student, J.L. Bonan, HM Rinder, and BR Smith Aspirin does not inhibit adenosine diphosphate-induced platelet alpha-granule release Blood 82 1993 505 512
17. M.B. Lucitt, S. O'Brien, J. Cowman, G Meade, L Basabe-Desmonts, and M Somers et al. Assaying the efficacy of dual-antiplatelet therapy: use of a controlled-shear-rate microfluidic device with a well-defined collagen surface to track dynamic platelet adhesion Anal Bioanal 14 2013 4823 4834
18. 12 inhibition on platelet thrombus volume in flowing blood J Thromb Haemost 9 2012 373 382
19. D. Bhatt, G.W. Stone, K.W. Mahaffey, M Gibson, PG Steg, and CW Hamm et al. Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events N Engl J Med 368 2013 1303 1313
20. A.D. Michelson Platelet Function Testing in Cardiovascular Diseases Circulation 110 2004 489 493
21. Y. Jeong, K.P. Bliden, M.J. Antonino, KS Park, US Tantry, and PA Gurbel Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies Am Heart J 164 2012 35 42
22. K. Hosokawa, T. Ohnishi, M. Fukasawa, T Koide, I Maruyama, and KA Tanaka A novel automated microchip flow chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions Microvasc Res 83 2011 154 161
23. K.B. Neeves, A.A. Onasogoa, R.R. Hansen, JJ Lilly, D Venckunaite, and MB Sumner et al. Sources of Variability in Platelet Accumulation on Type 1 Fibrillar Collagen in Microfluidic Flow Assays PLoS One 8 2013 e54680